Showing results (41-50 of 84) with videos related to
Sort By:
Pageof 9
European Heart Journal|September 29, 2011
Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approachesThomas Unger, Ludovit Paulis, Domenic A SicaNature Reviews. Cardiology|March 21, 2012
Key advances in antihypertensive treatmentLudovit Paulis, Ulrike M Steckelings, Thomas UngerExpert Opinion on Emerging Drugs|September 13, 2011
Emerging drugs which target the renin-angiotensin-aldosterone systemUlrike Muscha Steckelings, Ludovit Paulis, Thomas Unger, et al.General Physiology and Biophysics|June 12, 2020
Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implicationsJaroslav Hrenak, Stefan Zorad, Fedor SimkoCurrent Opinion in Nephrology and Hypertension|January 20, 2012
AT2 receptor agonists: hypertension and beyondUlrike M Steckelings, Ludovit Paulis, Pawel Namsolleck, et al.International Journal of Molecular Sciences|May 5, 2021
The Impact of microRNAs in Renin-Angiotensin-System-Induced Cardiac RemodellingMichaela Adamcova, Ippei Kawano, Fedor SimkoJournal of Hypertension|September 9, 2010
The angiotensin AT2 receptor in left ventricular hypertrophyU Muscha Steckelings, Robert E Widdop, Ludovit Paulis, et al.Current Pharmaceutical Design|March 29, 2022
Ivabradine in the Management of COVID-19-related Cardiovascular Complications: A PerspectiveTomas Baka, Kristina Repova, Ivan Luptak, et al.Medicinal Research Reviews|January 7, 2022
Cardiovascular therapeutics: A new potential for anxiety treatment?Kristina Repova, Silvia Aziriova, Kristina Krajcirovicova, et al.International Journal of Molecular Sciences|December 10, 2021
Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19Tomas Rajtik, Peter Galis, Linda Bartosova, et al.Pageof 9